Background Subclinical volume overload in the absence of diagnosed heart failure (HF)
may be an underrecognized contributor to kidney function decline in coronary artery disease …

We evaluated the cross-sectional associations of N-terminal pro-B-type natriuretic peptide
(NT-proBNP) with cardiac structural and functional abnormalities in a cohort of patients with …

Importance Contemporary clinical trials of heart failure with preserved ejection fraction
(HFpEF) apply natriuretic peptide (NP) thresholds to identify patients who are more likely to …

Background N-terminal pro-B-type natriuretic peptides (NT-proBNP) are guideline-
recommended biomarkers for risk stratification in patients with heart failure. However, NT …

Background The effect of impaired kidney function on B-type natriuretic peptide (BNP) and N-
terminal proBNP (NT-proBNP) is vague. This study was performed to examine the effect of …

Background NT-proBNP is an important predictor of mortality but is inversely related to
estimated glomerular filtration rate (eGFR). Whether the prognostic value of NT-proBNP is …

Importance Most studies, especially in primary prevention patients, have evaluated N-
terminal B-type natriuretic peptide (NT-proBNP) at one time point. Evaluation of change in …

The association between B-type natriuretic peptide (BNP) and cardiovascular (CV) events
and mortality has not been well characterized in patients with chronic kidney disease (CKD) …

Aims N‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP) values may be influenced by
patient factors beyond the severity of illness, including atrial fibrillation (AF), renal …

The precise mechanism explaining the increased N‐terminal pro‐B‐type natriuretic peptide
(NT‐proBNP) concentrations among patients with concomitant acute heart failure (AHF) and …